These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7043695)

  • 21. [Oral drug therapy of diabetes mellitus from the standpoint of blood insulin values].
    Murakami M; Takeda R; Miyabo S; Morimoto S; Fujimura A
    Saishin Igaku; 1967 Oct; 22(10):2311-9. PubMed ID: 5588196
    [No Abstract]   [Full Text] [Related]  

  • 22. [Studies on hypoglycemic effect of extract of Balaophora polyandra in mice].
    Tian JY; Ji TF; Su YL; Cong WN; Liu ZL; Ye F
    Zhongguo Zhong Yao Za Zhi; 2007 Jun; 32(12):1194-8. PubMed ID: 17802886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.
    Suskin N; McKelvie RS; Burns RJ; Latini R; Pericak D; Probstfield J; Rouleau JL; Sigouin C; Solymoss CB; Tsuyuki R; White M; Yusuf S
    Eur Heart J; 2000 Aug; 21(16):1368-75. PubMed ID: 10952826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidiabetic activity and toxicity of Zizyphus spina-christi leaves.
    Abdel-Zaher AO; Salim SY; Assaf MH; Abdel-Hady RH
    J Ethnopharmacol; 2005 Oct; 101(1-3):129-38. PubMed ID: 16009520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New trends in diabetes management.
    Stewart CE
    Emerg Med Serv; 2001 Nov; 30(11):80-8. PubMed ID: 11715797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus.
    Kim K; Kim H; Kwon J; Lee S; Kong H; Im SA; Lee YH; Lee YR; Oh ST; Jo TH; Park YI; Lee CK; Kim K
    Phytomedicine; 2009 Sep; 16(9):856-63. PubMed ID: 19303272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes of glycosilated hemoglobin during treatment of diabetes mellitus (author's transl)].
    Quibrera R; Nava M; Gómez-Chávez A; Ugalde ME
    Rev Invest Clin; 1980; 32(1):7-10. PubMed ID: 7414144
    [No Abstract]   [Full Text] [Related]  

  • 28. Insulin resistance and carbohydrate oxidation in patients with chemical diabetes.
    Chevaux F; Curchod B; Felber JP; Jéquier E
    Diabete Metab; 1982 Jun; 8(2):105-8. PubMed ID: 7049777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antidiabetic agents and renal insufficiency].
    Robles NR; Blanco J
    Nefrologia; 2002; 22(4):325-8. PubMed ID: 12369123
    [No Abstract]   [Full Text] [Related]  

  • 30. [Oral hypoglycemic agents in the treatment of elderly diabetics].
    Oba K
    Nihon Ronen Igakkai Zasshi; 2001 May; 38(3):288-90. PubMed ID: 11431871
    [No Abstract]   [Full Text] [Related]  

  • 31. [Investigation of insulin resistance in fourteen children starting a diabetes mellitus (author's transl)].
    Dieterlen P; Grasset E; Aubry E; Deschamps I; Desjeux JF; Lestradet H
    Ann Pediatr (Paris); 1981 Sep; 28(7):493-6. PubMed ID: 7025730
    [No Abstract]   [Full Text] [Related]  

  • 32. [Trust is good, control is better. Glucose tests, insulin syringes, needles].
    Fink E
    Pharm Unserer Zeit; 2001 Jan; 30(1):34-9. PubMed ID: 11233181
    [No Abstract]   [Full Text] [Related]  

  • 33. [Influence of pentoxifylline on glycometabolic balance in diabetic subjects].
    Ferlito S; Mangiagli P; Di Mauro C
    Clin Ter; 1981 Jun; 97(6):613-8. PubMed ID: 7023805
    [No Abstract]   [Full Text] [Related]  

  • 34. Nateglinide--current and future role in the treatment of patients with type 2 diabetes mellitus.
    Campbell IW
    Int J Clin Pract; 2005 Oct; 59(10):1218-28. PubMed ID: 16178991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood glucose and serum insulin in stable diabetics after ingestion of bread].
    Bonnevie-Nielsen V
    Ugeskr Laeger; 1980 Mar; 142(11):686-8. PubMed ID: 6989070
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of compensation on the basal blood level of contrainsular hormones in diabetics].
    Vakov L
    Vutr Boles; 1986; 25(4):66-72. PubMed ID: 3532564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Constraints to benefits obtained, capillary blood glucose utility in treatment].
    Bodin F
    Rev Infirm; 2008 Jun; (141):18-20. PubMed ID: 18669379
    [No Abstract]   [Full Text] [Related]  

  • 39. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Urinary steroids ad glycaemia in diabetics and non-diabetics (author's transl)].
    Barták V; Stárka L; Homolka J; Visnák K
    Cas Lek Cesk; 1982 Apr; 121(16):494-8. PubMed ID: 7093984
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.